Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation. (Q39018398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

review article

1 reference

title

Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

Juan Duarte

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

Rosario Jiménez

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

1

Marta Toral

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

Francisco Pérez-Vizcaíno

series ordinal

3

object named as

Francisco Pérez-Vizcaíno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

publication date

23 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

volume

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

H189-H200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPAR ligands: are they potential agents for cardiovascular disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

R4 RGS proteins: regulation of G-protein signaling and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Modulation of PPAR activity via phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Multiple genes for essential-hypertension susceptibility on chromosome 1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Leukocyte adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: are the reagents beneficial or harmful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Screening of Peroxisome Proliferator-Activated Receptors (PPARs) α, γ and α Gene Polymorphisms for Obesity and Metabolic Syndrome Association in the Multi-Ethnic Malaysian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

A PPAR-β/δ agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Emerging roles of PPARs in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARs: the vasculature, inflammation and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

21 January 2018

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome Proliferator-Activated Receptor beta/delta in the Brain: Facts and Hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARs and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARdelta regulates glucose metabolism and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlcNAcylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARδ agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Identification of a series of PPAR gamma/delta dual agonists via solid-phase parallel synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Harnessing the benefits of PPARβ/δ agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Regulator of G protein signaling 5: a new player in vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Inflammation, immunity, and hypertensive end-organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Physiological functions of peroxisome proliferator-activated receptor β

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARs and their Effects on the Cardiovascular System

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Establishing the Role of PPARβ/δ in Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Oxidative stress in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Adaptation of resistance arteries to increases in pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Alterations in cardiac structure and function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

The next generation of PPAR drugs: do we have the tools to find them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Alteration of a single amino acid in peroxisome proliferator-activated receptor-alpha (PPAR alpha) generates a PPAR delta phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Critical roles of PPAR beta/delta in keratinocyte response to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARδ activation protects endothelial function in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptors for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Cytokines and vascular reactivity in resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00155.2016

10.1152/AJPHEART.00155.2016

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27881385 AND SRC:MED&resulttype=core&format=json

28 March 2020

1 reference